BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 38529301)

  • 1. Reference intervals of Cyfra21-1 and CEA in healthy adult Han Chinese population.
    Xing L; Zhao S; Gao S; Shi X; Huang Y; Bian P; Sun J
    Pract Lab Med; 2024 May; 40():e00409. PubMed ID: 38846326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
    Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
    PeerJ; 2024; 12():e17141. PubMed ID: 38529301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y; Wang Z; Ding Y; Sun F; Ding X
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma.
    Li Z; Wu W; Pan X; Li F; Zhu Q; He Z; Chen L
    Cancer Med; 2022 Jul; 11(14):2855-2864. PubMed ID: 35289087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer.
    Florescu DN; Boldeanu MV; Șerban RE; Florescu LM; Serbanescu MS; Ionescu M; Streba L; Constantin C; Vere CC
    Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer.
    Berger K; Persson E; Gregersson P; Ruiz-Martínez S; Jonasson E; Ståhlberg A; Rhost S; Landberg G
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker.
    Yan X; Han L; Zhao R; Fatima S; Zhao L; Gao F
    Heliyon; 2022 Aug; 8(8):e09953. PubMed ID: 35928100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
    Fang Y; Li Z; Chen H; Zhang T; Yin X; Man J; Yang X; Lu M
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3209-3218. PubMed ID: 35904601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer.
    Li J; Chen Y; Wang X; Wang C; Xiao M
    Transl Cancer Res; 2021 Apr; 10(4):1900-1906. PubMed ID: 35116511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Three-dimensional Image Simulation in Surgical Resection of Early-stage Lung Cancer.
    Lin KH; Huang YJ; Lee SC; Huang HK; Chen YY; Chang H; Wu TH; Sung BY; Huang TW
    Ann Thorac Surg; 2022 Sep; 114(3):1029-1034. PubMed ID: 34389306
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.